VIKAS MALHOTRA
- Type
- Physician · Allopathic & Osteopathic Physicians / Internal Medicine / Medical Oncology
- Where
- SPRING HILL, FL
- NPI
- 1821058496
- Received
- $58,232 in 872 records, 2019 to 2025
- Source
- CMS Open Payments search ↗
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2025 | General payment | 144 | $6,127 |
| 2024 | General payment | 133 | $8,373 |
| 2023 | General payment | 103 | $5,905 |
| 2022 | General payment | 67 | $6,128 |
| 2021 | General payment | 78 | $9,428 |
| 2020 | General payment | 136 | $11,429 |
| 2019 | General payment | 211 | $10,840 |
By company
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Consulting Fee | 15 | $31,240 |
| Food and Beverage | 825 | $14,375 |
| Honoraria | 10 | $9,738 |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a v | 2 | $1,698 |
| Education | 16 | $909 |
| Travel and Lodging | 4 | $270 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2025-12-19 | Legend Biotech USA Inc. | $24 | Food and Beverage | In-kind items and services | CARVYKTI Biological, Oncology | 2025 | |
| 2025-12-15 | PUMA BIOTECHNOLOGY, INC. | $23 | Food and Beverage | In-kind items and services | NERLYNX Drug, ONCOLOGY | 2025 | |
| 2025-12-12 | Novartis Pharmaceuticals Corporation | $20 | Food and Beverage | In-kind items and services | KISQALI Drug, Oncology | 2025 | |
| 2025-12-10 | E.R. Squibb & Sons, L.L.C. | $19 | Food and Beverage | Cash or cash equivalent | OPDIVO Biological, Oncology | 2025 | |
| 2025-12-09 | Eisai Inc. | $16 | Food and Beverage | In-kind items and services | Lenvima Drug, Oncology | 2025 | |
| 2025-12-08 | ARRAY BIOPHARMA INC | $15 | Food and Beverage | In-kind items and services | LORBRENA Drug, ONCOLOGY | 2025 | |
| 2025-12-04 | Incyte Corporation | $27 | Food and Beverage | Cash or cash equivalent | MONJUVI Drug, Oncology | 2025 | |
| 2025-12-03 | E.R. Squibb & Sons, L.L.C. | $16 | Food and Beverage | Cash or cash equivalent | OPDIVO Biological, Oncology | 2025 | |
| 2025-12-01 | Regeneron Healthcare Solutions, Inc. | $28 | Food and Beverage | In-kind items and services | LIBTAYO Biological, ONCOLOGY | 2025 | |
| 2025-11-20 | Astellas Pharma US Inc | $22 | Food and Beverage | In-kind items and services | Xtandi Drug, Oncology | 2025 | |
| 2025-11-19 | Eisai Inc. | $20 | Food and Beverage | In-kind items and services | Lenvima Drug, Oncology | 2025 | |
| 2025-11-14 | SOBI, INC | $29 | Food and Beverage | In-kind items and services | Vonjo Drug, Hematology/Oncology | 2025 | |
| 2025-11-12 | Amgen Inc. | $16 | Food and Beverage | In-kind items and services | KYPROLIS Drug, Oncology | 2025 | |
| 2025-11-07 | Novartis Pharmaceuticals Corporation | $20 | Food and Beverage | In-kind items and services | KISQALI Drug, Oncology | 2025 | |
| 2025-11-06 | GlaxoSmithKline, LLC. | $24 | Food and Beverage | In-kind items and services | BLENREP Biological, ONCOLOGY | 2025 | |
| 2025-11-05 | AstraZeneca Pharmaceuticals LP | $27 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-11-04 | PFIZER INC. | $24 | Food and Beverage | In-kind items and services | PADCEV Biological, ONCOLOGY | 2025 | |
| 2025-10-30 | Medtronic, Inc. | $21 | Food and Beverage | In-kind items and services | INTELLIS ADAPTIVESTIM Device, Spinal Cord Neurostimulation | 2025 | |
| 2025-10-30 | ARRAY BIOPHARMA INC | $20 | Food and Beverage | In-kind items and services | BRAFTOVI Drug, ONCOLOGY | 2025 | |
| 2025-10-29 | Bayer Healthcare Pharmaceuticals Inc. | $17 | Food and Beverage | In-kind items and services | Nubeqa Drug, Oncology | 2025 | |
| 2025-10-27 | KYOWA KIRIN, INC. | $29 | Food and Beverage | In-kind items and services | POTELIGEO Drug, MONOCLONAL ANTIBODY | 2025 | |
| 2025-10-24 | Stemline Therapeutics Inc. | $19 | Food and Beverage | In-kind items and services | Orserdu Drug, Oncology | 2025 | |
| 2025-10-23 | Bayer Healthcare Pharmaceuticals Inc. | $16 | Food and Beverage | In-kind items and services | Nubeqa Drug, Oncology | 2025 | |
| 2025-10-17 | Novartis Pharmaceuticals Corporation | $30 | Food and Beverage | In-kind items and services | SCEMBLIX Drug, Oncology | 2025 | |
| 2025-10-08 | Astellas Pharma US Inc | $17 | Food and Beverage | In-kind items and services | Vyloy Drug, Oncology | 2025 | |
| 2025-10-07 | Janssen Biotech, Inc. | $18 | Food and Beverage | In-kind items and services | RYBREVANT Drug, Oncology | 2025 | |
| 2025-10-06 | TAIHO ONCOLOGY, INC. | $15 | Food and Beverage | In-kind items and services | LONSURF Drug, Oncology | 2025 | |
| 2025-10-02 | BeOne Medicines USA, Inc. | $21 | Food and Beverage | In-kind items and services | BRUKINSA Drug, Oncology | 2025 | |
| 2025-10-01 | Geron Corporation | $20 | Food and Beverage | In-kind items and services | RYTELO Drug, MYELODYSPLASTIC SYNDROME | 2025 | |
| 2025-10-01 | Tactile Systems Technology Inc | $19 | Food and Beverage | In-kind items and services | Flexitouch Plus Device, PNEUMATIC COMPRESSOR | 2025 | |
| 2025-09-29 | Incyte Corporation | $24 | Food and Beverage | Cash or cash equivalent | JAKAFI Drug, Hematology/Oncology | 2025 | |
| 2025-09-29 | GENZYME CORPORATION | $16 | Food and Beverage | In-kind items and services | WAYRILZ Drug, Immunology | 2025 | |
| 2025-09-26 | Genmab U.S., Inc. | $13 | Food and Beverage | In-kind items and services | Epkinly Drug, Oncology | 2025 | |
| 2025-09-25 | Aveo Pharmaceuticals, Inc. | $14 | Food and Beverage | In-kind items and services | FOTIVDA Drug, Oncology | 2025 | |
| 2025-09-24 | EMD Serono, Inc. | $20 | Food and Beverage | Cash or cash equivalent | 2025 | ||
| 2025-09-22 | AstraZeneca Pharmaceuticals LP | $17 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-09-18 | E.R. Squibb & Sons, L.L.C. | $23 | Food and Beverage | Cash or cash equivalent | OPDUALAG Drug, Oncology | 2025 | |
| 2025-09-17 | Incyte Corporation | $16 | Food and Beverage | Cash or cash equivalent | MONJUVI Drug, Oncology | 2025 | |
| 2025-09-16 | Gilead Sciences, Inc. | $23 | Food and Beverage | In-kind items and services | Trodelvy Drug, ONC | 2025 | |
| 2025-09-15 | PFIZER INC. | $19 | Food and Beverage | In-kind items and services | IBRANCE Drug, ONCOLOGY | 2025 | |
| 2025-09-12 | Janssen Biotech, Inc. | $23 | Food and Beverage | In-kind items and services | RYBREVANT Drug, Oncology | 2025 | |
| 2025-09-12 | Novartis Pharmaceuticals Corporation | $20 | Food and Beverage | In-kind items and services | KISQALI Drug, Oncology | 2025 | |
| 2025-09-11 | Incyte Corporation | $30 | Food and Beverage | Cash or cash equivalent | MONJUVI Drug, Oncology | 2025 | |
| 2025-09-04 | Daiichi Sankyo Inc. | $23 | Food and Beverage | In-kind items and services | DATROWAY Drug, ONCOLOGY | 2025 | |
| 2025-09-04 | AstraZeneca Pharmaceuticals LP | $16 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-09-03 | Kite Pharma, Inc. | $27 | Food and Beverage | In-kind items and services | Yescarta Drug, CELLT | 2025 | |
| 2025-08-29 | Janssen Biotech, Inc. | $32 | Food and Beverage | In-kind items and services | TALVEY Biological, Oncology | 2025 | |
| 2025-08-29 | Janssen Biotech, Inc. | $0 | Food and Beverage | In-kind items and services | TALVEY Biological, Oncology | 2025 | |
| 2025-08-28 | Bayer Healthcare Pharmaceuticals Inc. | $19 | Food and Beverage | In-kind items and services | Nubeqa Drug, Oncology | 2025 | |
| 2025-08-25 | ARRAY BIOPHARMA INC | $15 | Food and Beverage | In-kind items and services | XALKORI Drug, ONCOLOGY | 2025 | |
| 2025-08-18 | BeOne Medicines USA, Inc. | $29 | Food and Beverage | In-kind items and services | TEVIMBRA Drug, Oncology | 2025 | |
| 2025-08-18 | BeOne Medicines USA, Inc. | $9 | Food and Beverage | In-kind items and services | TEVIMBRA Drug, Oncology | 2025 | |
| 2025-08-15 | Boehringer Ingelheim Pharmaceuticals, Inc. | $21 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-08-14 | Celgene Corporation | $21 | Food and Beverage | Cash or cash equivalent | REBLOZYL Biological, Hematology | 2025 | |
| 2025-08-12 | Eisai Inc. | $15 | Food and Beverage | In-kind items and services | Lenvima Drug, Oncology | 2025 | |
| 2025-08-11 | Incyte Corporation | $29 | Food and Beverage | Cash or cash equivalent | MONJUVI Drug, Oncology | 2025 | |
| 2025-08-06 | GlaxoSmithKline, LLC. | $33 | Food and Beverage | In-kind items and services | OJJAARA Drug, ONCOLOGY | 2025 | |
| 2025-08-04 | Legend Biotech USA Inc. | $32 | Food and Beverage | In-kind items and services | CARVYKTI Biological, Oncology | 2025 | |
| 2025-08-02 | Astellas Pharma US Inc | $15 | Food and Beverage | In-kind items and services | Xtandi Drug, Oncology | 2025 | |
| 2025-07-31 | Merck Sharp & Dohme LLC | $17 | Food and Beverage | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | 2025 | |
| 2025-07-30 | Merck Sharp & Dohme LLC | $16 | Food and Beverage | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | 2025 | |
| 2025-07-28 | Geron Corporation | $21 | Food and Beverage | In-kind items and services | RYTELO Drug, MYELODYSPLASTIC SYNDROME | 2025 | |
| 2025-07-25 | JAZZ PHARMACEUTICALS INC. | $19 | Food and Beverage | In-kind items and services | ZEPZELCA Drug, HEMATOLOGY/ONCOLOGY | 2025 | |
| 2025-07-24 | Regeneron Healthcare Solutions, Inc. | $30 | Food and Beverage | In-kind items and services | LIBTAYO Biological, ONCOLOGY | 2025 | |
| 2025-07-23 | Merck Sharp & Dohme LLC | $28 | Food and Beverage | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | 2025 | |
| 2025-07-22 | Telix Pharmaceuticals | $24 | Food and Beverage | In-kind items and services | ILLUCCIX Drug, PROSTATE CANCER DIAGNOSIS | 2025 | |
| 2025-07-11 | Merck Sharp & Dohme LLC | $21 | Food and Beverage | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | 2025 | |
| 2025-07-10 | Legend Biotech USA Inc. | $27 | Food and Beverage | In-kind items and services | CARVYKTI Biological, Oncology | 2025 | |
| 2025-07-08 | Janssen Biotech, Inc. | $19 | Food and Beverage | In-kind items and services | RYBREVANT Drug, Oncology | 2025 | |
| 2025-07-07 | Incyte Corporation | $18 | Food and Beverage | Cash or cash equivalent | JAKAFI Drug, Hematology/Oncology | 2025 | |
| 2025-07-03 | Incyte Corporation | $17 | Food and Beverage | Cash or cash equivalent | JAKAFI Drug, Hematology/Oncology | 2025 | |
| 2025-07-02 | PFIZER INC. | $12 | Food and Beverage | In-kind items and services | HYMPAVZI Drug, IMMUNOLOGY | 2025 | |
| 2025-06-27 | AstraZeneca Pharmaceuticals LP | $13 | Food and Beverage | In-kind items and services | ENHERTU Biological, Oncology | 2025 | |
| 2025-06-23 | Regeneron Healthcare Solutions, Inc. | $36 | Food and Beverage | In-kind items and services | LIBTAYO Biological, ONCOLOGY | 2025 | |
| 2025-06-18 | BeOne Medicines USA, Inc. | $23 | Food and Beverage | In-kind items and services | BRUKINSA Drug, Oncology | 2025 | |
| 2025-06-16 | ABBVIE INC. | $16 | Food and Beverage | In-kind items and services | EMRELIS Drug, ONCOLOGY | 2025 | |
| 2025-06-12 | Eisai Inc. | $22 | Food and Beverage | In-kind items and services | Lenvima Drug, Oncology | 2025 | |
| 2025-06-11 | BeOne Medicines USA, Inc. | $25 | Food and Beverage | In-kind items and services | TEVIMBRA Drug, Oncology | 2025 | |
| 2025-06-06 | PUMA BIOTECHNOLOGY, INC. | $13 | Food and Beverage | In-kind items and services | NERLYNX Drug, ONCOLOGY | 2025 | |
| 2025-06-04 | Novartis Pharmaceuticals Corporation | $27 | Food and Beverage | In-kind items and services | KISQALI Drug, Oncology | 2025 | |
| 2025-06-04 | Agios Pharmaceuticals, Inc. | $15 | Food and Beverage | In-kind items and services | PYRUKYND Drug, Genetically Defined Disease | 2025 | |
| 2025-05-30 | Merck Sharp & Dohme LLC | $22 | Food and Beverage | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | 2025 | |
| 2025-05-29 | Celgene Corporation | $26 | Food and Beverage | Cash or cash equivalent | REBLOZYL Biological, Hematology | 2025 | |
| 2025-05-29 | Bayer Healthcare Pharmaceuticals Inc. | $19 | Food and Beverage | In-kind items and services | Nubeqa Drug, Oncology | 2025 | |
| 2025-05-27 | Celgene Corporation | $18 | Food and Beverage | Cash or cash equivalent | REBLOZYL Biological, Hematology | 2025 | |
| 2025-05-22 | Incyte Corporation | $17 | Food and Beverage | Cash or cash equivalent | MONJUVI Drug, Oncology | 2025 | |
| 2025-05-22 | GlaxoSmithKline, LLC. | $15 | Food and Beverage | In-kind items and services | OJJAARA Drug, ONCOLOGY | 2025 | |
| 2025-05-20 | Lilly USA, LLC | $18 | Food and Beverage | In-kind items and services | VERZENIO Drug, Oncology | 2025 | |
| 2025-05-19 | AstraZeneca Pharmaceuticals LP | $19 | Food and Beverage | In-kind items and services | ENHERTU Biological, Oncology | 2025 | |
| 2025-05-02 | Janssen Biotech, Inc. | $15 | Food and Beverage | In-kind items and services | TALVEY Biological, Oncology | 2025 | |
| 2025-05-01 | Janssen Biotech, Inc. | $0 | Food and Beverage | In-kind items and services | TALVEY Biological, Oncology | 2025 | |
| 2025-04-29 | Acrotech Biopharma Inc. | $64 | Food and Beverage | In-kind items and services | BELEODAQ Drug, ONCOLOGY | 2025 | |
| 2025-04-26 | Regeneron Healthcare Solutions, Inc. | $30 | Food and Beverage | In-kind items and services | LIBTAYO Biological, ONCOLOGY | 2025 | |
| 2025-04-18 | Celgene Corporation | $25 | Food and Beverage | Cash or cash equivalent | REBLOZYL Biological, Hematology | 2025 | |
| 2025-04-18 | Novartis Pharmaceuticals Corporation | $14 | Food and Beverage | In-kind items and services | Fabhalta Drug, Immunology | 2025 | |
| 2025-04-15 | SEAGEN INC. | $99 | Education | In-kind items and services | 2025 | ||
| 2025-04-14 | BeOne Medicines USA, Inc. | $28 | Food and Beverage | In-kind items and services | BRUKINSA Drug, Oncology | 2025 | |
| 2025-04-14 | BeOne Medicines USA, Inc. | $10 | Food and Beverage | In-kind items and services | TEVIMBRA Drug, Oncology | 2025 | |
| 2025-04-10 | PFIZER INC. | $18 | Food and Beverage | In-kind items and services | XTANDI Drug, ONCOLOGY | 2025 | |
| 2025-04-08 | Janssen Biotech, Inc. | $12 | Food and Beverage | In-kind items and services | RYBREVANT Drug, Oncology | 2025 | |
| 2025-04-07 | Novartis Pharmaceuticals Corporation | $20 | Food and Beverage | In-kind items and services | PLUVICTO Drug, Oncology | 2025 | |
| 2025-04-04 | Merck Sharp & Dohme LLC | $16 | Food and Beverage | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | 2025 | |
| 2025-04-03 | PFIZER INC. | $26 | Food and Beverage | In-kind items and services | IBRANCE Drug, ONCOLOGY | 2025 | |
| 2025-04-03 | PFIZER INC. | $1 | Food and Beverage | In-kind items and services | IBRANCE Drug, ONCOLOGY | 2025 | |
| 2025-04-01 | Daiichi Sankyo Inc. | $22 | Food and Beverage | In-kind items and services | Enhertu Drug, ONCOLOGY | 2025 | |
| 2025-03-28 | PFIZER INC. | $17 | Food and Beverage | In-kind items and services | BOSULIF Drug, METABOLIC DISEASE;ONCOLOGY | 2025 | |
| 2025-03-26 | Novartis Pharmaceuticals Corporation | $27 | Food and Beverage | In-kind items and services | KISQALI Drug, Oncology | 2025 | |
| 2025-03-25 | Syndax Pharmaceuticals, Inc. | $14 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-03-25 | Janssen Biotech, Inc. | $13 | Food and Beverage | In-kind items and services | ERLEADA Drug, Oncology | 2025 | |
| 2025-03-20 | ARRAY BIOPHARMA INC | $78 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | LORBRENA Drug, ONCOLOGY | 2025 | |
| 2025-03-20 | Dendreon Pharmaceuticals LLC | $23 | Food and Beverage | In-kind items and services | PROVENGE Drug, CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | 2025 | |
| 2025-03-20 | Gilead Sciences, Inc. | $21 | Food and Beverage | In-kind items and services | Trodelvy Drug, ONC | 2025 | |
| 2025-03-17 | GENZYME CORPORATION | $32 | Food and Beverage | In-kind items and services | SARCLISA Biological, Oncology | 2025 | |
| 2025-03-14 | Celgene Corporation | $23 | Food and Beverage | Cash or cash equivalent | REBLOZYL Biological, Hematology | 2025 | |
| 2025-03-13 | Gilead Sciences, Inc. | $28 | Food and Beverage | In-kind items and services | Trodelvy Drug, ONC | 2025 | |
| 2025-03-11 | PFIZER INC. | $25 | Food and Beverage | In-kind items and services | INLYTA Drug, ONCOLOGY | 2025 | |
| 2025-03-11 | PFIZER INC. | $0 | Food and Beverage | In-kind items and services | INLYTA Drug, ONCOLOGY | 2025 | |
| 2025-03-10 | Kite Pharma, Inc. | $22 | Food and Beverage | In-kind items and services | Yescarta Drug, CELLT | 2025 | |
| 2025-03-06 | AstraZeneca Pharmaceuticals LP | $3,015 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-02-28 | PFIZER INC. | $22 | Food and Beverage | In-kind items and services | INLYTA Drug, ONCOLOGY | 2025 | |
| 2025-02-27 | Merck Sharp & Dohme LLC | $24 | Food and Beverage | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | 2025 | |
| 2025-02-26 | Janssen Biotech, Inc. | $13 | Food and Beverage | In-kind items and services | RYBREVANT Drug, Oncology | 2025 | |
| 2025-02-24 | AstraZeneca Pharmaceuticals LP | $18 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-02-20 | Bayer Healthcare Pharmaceuticals Inc. | $25 | Food and Beverage | In-kind items and services | Nubeqa Drug, Oncology | 2025 | |
| 2025-02-19 | Eisai Inc. | $16 | Food and Beverage | In-kind items and services | Lenvima Drug, Oncology | 2025 | |
| 2025-02-17 | Janssen Biotech, Inc. | $16 | Food and Beverage | In-kind items and services | TECVAYLI Biological, Oncology | 2025 | |
| 2025-02-16 | Janssen Biotech, Inc. | $7 | Food and Beverage | In-kind items and services | TALVEY Biological, Oncology | 2025 | |
| 2025-02-13 | Eisai Inc. | $26 | Food and Beverage | In-kind items and services | Lenvima Drug, Oncology | 2025 | |
| 2025-02-06 | Celgene Corporation | $15 | Food and Beverage | Cash or cash equivalent | REBLOZYL Biological, Hematology | 2025 | |
| 2025-02-06 | Celgene Corporation | $14 | Food and Beverage | Cash or cash equivalent | REBLOZYL Biological, Hematology | 2025 | |
| 2025-02-06 | Celgene Corporation | $13 | Food and Beverage | Cash or cash equivalent | REBLOZYL Biological, Hematology | 2025 | |
| 2025-02-05 | Geron Corporation | $22 | Food and Beverage | In-kind items and services | RYTELO Drug, MYELODYSPLASTIC SYNDROME | 2025 | |
| 2025-01-31 | Merck Sharp & Dohme LLC | $22 | Food and Beverage | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | 2025 | |
| 2025-01-30 | Celgene Corporation | $11 | Food and Beverage | Cash or cash equivalent | REBLOZYL Biological, Hematology | 2025 | |
| 2025-01-28 | TAIHO ONCOLOGY, INC. | $14 | Food and Beverage | In-kind items and services | LONSURF Drug, Oncology | 2025 | |
| 2025-01-27 | PFIZER INC. | $22 | Food and Beverage | In-kind items and services | INLYTA Drug, ONCOLOGY | 2025 | |
| 2025-01-24 | E.R. Squibb & Sons, L.L.C. | $22 | Food and Beverage | Cash or cash equivalent | OPDIVO Biological, Oncology | 2025 | |
| 2025-01-23 | Merck Sharp & Dohme LLC | $23 | Food and Beverage | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | 2025 | |
| 2025-01-21 | Janssen Biotech, Inc. | $22 | Food and Beverage | In-kind items and services | RYBREVANT Drug, Oncology | 2025 | |
| 2025-01-17 | Merck Sharp & Dohme LLC | $17 | Food and Beverage | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | 2025 | |
| 2025-01-15 | Eisai Inc. | $22 | Food and Beverage | In-kind items and services | Lenvima Drug, Oncology | 2025 | |
| 2025-01-10 | KYOWA KIRIN, INC. | $29 | Food and Beverage | In-kind items and services | POTELIGEO Drug, MONOCLONAL ANTIBODY | 2025 | |
| 2025-01-09 | AstraZeneca Pharmaceuticals LP | $25 | Food and Beverage (5 payments) | In-kind items and services | CALQUENCE Drug, Oncology | 2025 | |
| 2025-01-02 | Astellas Pharma US Inc | $22 | Food and Beverage | In-kind items and services | Vyloy Drug, Oncology | 2025 | |
| 2024-12-31 | PFIZER INC. | $2,880 | Consulting Fee | Cash or cash equivalent | PADCEV Biological, Oncology | 2024 | |
| 2024-12-20 | Gilead Sciences, Inc. | $29 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-12-20 | Regeneron Healthcare Solutions, Inc. | $16 | Food and Beverage | In-kind items and services | LIBTAYO Biological, ONCOLOGY | 2024 | |
| 2024-12-18 | Novartis Pharmaceuticals Corporation | $23 | Food and Beverage | In-kind items and services | LUTATHERA Drug, Oncology | 2024 | |
| 2024-12-17 | AstraZeneca Pharmaceuticals LP | $1,387 | Consulting Fee | Cash or cash equivalent | 2024 | ||
| 2024-12-17 | JAZZ PHARMACEUTICALS INC. | $14 | Food and Beverage | In-kind items and services | ZEPZELCA Drug, HEMATOLOGY/ONCOLOGY | 2024 | |
| 2024-12-13 | Celgene Corporation | $22 | Food and Beverage | Cash or cash equivalent | REBLOZYL Biological, Hematology | 2024 | |
| 2024-12-06 | Gilead Sciences, Inc. | $22 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-12-05 | Lilly USA, LLC | $25 | Food and Beverage | In-kind items and services | VERZENIO Drug, Oncology | 2024 | |
| 2024-12-04 | Aveo Pharmaceuticals, Inc. | $20 | Food and Beverage | In-kind items and services | FOTIVDA Drug, Oncology | 2024 | |
| 2024-12-02 | Novartis Pharmaceuticals Corporation | $15 | Food and Beverage | In-kind items and services | KISQALI Drug, Oncology | 2024 | |
| 2024-11-25 | Novartis Pharmaceuticals Corporation | $15 | Food and Beverage | In-kind items and services | Fabhalta Drug, Immunology | 2024 | |
| 2024-11-22 | Rigel Pharmaceuticals, Inc. | $29 | Food and Beverage | Cash or cash equivalent | Rezlidhia Drug, Acute Myeloid Leukemia | 2024 | |
| 2024-11-15 | GlaxoSmithKline, LLC. | $18 | Food and Beverage | In-kind items and services | JEMPERLI Biological, ONCOLOGY | 2024 | |
| 2024-11-14 | E.R. Squibb & Sons, L.L.C. | $25 | Food and Beverage | Cash or cash equivalent | KRAZATI Drug, Oncology | 2024 | |
| 2024-11-14 | E.R. Squibb & Sons, L.L.C. | $0 | Food and Beverage | Cash or cash equivalent | KRAZATI Drug, Oncology | 2024 | |
| 2024-11-11 | PFIZER INC. | $22 | Food and Beverage | In-kind items and services | INLYTA Drug, ONCOLOGY | 2024 | |
| 2024-11-07 | GlaxoSmithKline, LLC. | $23 | Food and Beverage | In-kind items and services | OJJAARA Drug, ONCOLOGY | 2024 | |
| 2024-11-06 | Daiichi Sankyo Inc. | $15 | Food and Beverage | In-kind items and services | Enhertu Drug, ONCOLOGY | 2024 | |
| 2024-11-05 | Incyte Corporation | $49 | Education | Cash or cash equivalent | 2024 | ||
| 2024-11-04 | Celgene Corporation | $12 | Food and Beverage | Cash or cash equivalent | REBLOZYL Biological, Hematology | 2024 | |
| 2024-11-04 | Celgene Corporation | $2 | Food and Beverage | Cash or cash equivalent | REBLOZYL Biological, Hematology | 2024 | |
| 2024-11-01 | Lilly USA, LLC | $18 | Food and Beverage | In-kind items and services | VERZENIO Drug, Oncology | 2024 | |
| 2024-10-31 | PFIZER INC. | $24 | Food and Beverage | In-kind items and services | IBRANCE Drug, ONCOLOGY | 2024 | |
| 2024-10-28 | Novartis Pharmaceuticals Corporation | $25 | Food and Beverage | In-kind items and services | KISQALI Drug, Oncology | 2024 | |
| 2024-10-25 | PFIZER INC. | $1,620 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | PADCEV Biological, Oncology | 2024 | |
| 2024-10-25 | Novartis Pharmaceuticals Corporation | $13 | Food and Beverage | In-kind items and services | MEKINIST Drug, Oncology | 2024 | |
| 2024-10-25 | Novartis Pharmaceuticals Corporation | $0 | Food and Beverage | In-kind items and services | MEKINIST Drug, Oncology | 2024 | |
| 2024-10-17 | Incyte Corporation | $18 | Food and Beverage | Cash or cash equivalent | MONJUVI Drug, Oncology | 2024 | |
| 2024-10-05 | Astellas Pharma US Inc | $24 | Food and Beverage | In-kind items and services | Xtandi Drug, Oncology | 2024 | |
| 2024-10-04 | Celgene Corporation | $16 | Food and Beverage | Cash or cash equivalent | REBLOZYL Biological, Hematology | 2024 | |
| 2024-10-03 | Novartis Pharmaceuticals Corporation | $22 | Food and Beverage | In-kind items and services | KISQALI Drug, Oncology | 2024 | |
| 2024-10-03 | Novartis Pharmaceuticals Corporation | $0 | Food and Beverage | In-kind items and services | KISQALI Drug, Oncology | 2024 | |
| 2024-10-02 | GENZYME CORPORATION | $28 | Food and Beverage | In-kind items and services | SARCLISA Biological, Oncology | 2024 | |
| 2024-09-30 | PFIZER INC. | $13 | Food and Beverage | In-kind items and services | PADCEV Biological, Oncology | 2024 | |
| 2024-09-30 | PFIZER INC. | $3 | Food and Beverage | In-kind items and services | PADCEV Biological, Oncology | 2024 | |
| 2024-09-25 | Stemline Therapeutics Inc. | $29 | Food and Beverage | In-kind items and services | Orserdu Drug, Oncology | 2024 | |
| 2024-09-24 | Stemline Therapeutics Inc. | $14 | Food and Beverage | In-kind items and services | Orserdu Drug, Oncology | 2024 | |
| 2024-09-20 | E.R. Squibb & Sons, L.L.C. | $19 | Food and Beverage | Cash or cash equivalent | OPDUALAG Drug, Oncology | 2024 | |
| 2024-09-19 | Celgene Corporation | $21 | Food and Beverage | Cash or cash equivalent | REBLOZYL Biological, Hematology | 2024 | |
| 2024-09-17 | Janssen Biotech, Inc. | $18 | Food and Beverage | In-kind items and services | RYBREVANT Drug, Oncology | 2024 | |
| 2024-09-17 | PFIZER INC. | $6 | Food and Beverage | In-kind items and services | ELIQUIS Drug, CARDIOVASCULAR;METABOLIC DISEASE | 2024 | |
| 2024-09-16 | Eisai Inc. | $19 | Food and Beverage | In-kind items and services | Lenvima Drug, Oncology | 2024 | |
| 2024-09-13 | Regeneron Healthcare Solutions, Inc. | $21 | Food and Beverage | In-kind items and services | LIBTAYO Biological, ONCOLOGY | 2024 | |
| 2024-09-12 | PUMA BIOTECHNOLOGY, INC. | $19 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-09-09 | PFIZER INC. | $24 | Food and Beverage | In-kind items and services | IBRANCE Drug, ONCOLOGY | 2024 | |
| 2024-09-06 | Gilead Sciences, Inc. | $16 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-09-05 | Gilead Sciences, Inc. | $28 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-08-29 | Stemline Therapeutics Inc. | $26 | Food and Beverage | In-kind items and services | Orserdu Drug, Oncology | 2024 | |
| 2024-08-29 | Celgene Corporation | $18 | Food and Beverage | Cash or cash equivalent | REBLOZYL Biological, Hematology | 2024 | |
| 2024-08-26 | Novartis Pharmaceuticals Corporation | $17 | Food and Beverage | In-kind items and services | PLUVICTO Drug, Oncology | 2024 | |
| 2024-08-23 | E.R. Squibb & Sons, L.L.C. | $19 | Food and Beverage | Cash or cash equivalent | OPDIVO Biological, Oncology | 2024 | |
| 2024-08-21 | Celgene Corporation | $20 | Food and Beverage | Cash or cash equivalent | REBLOZYL Biological, Hematology | 2024 | |
| 2024-08-16 | Alnylam Pharmaceuticals Inc. | $18 | Food and Beverage | In-kind items and services | GIVLAARI Drug, Genetic Disease | 2024 | |
| 2024-08-09 | E.R. Squibb & Sons, L.L.C. | $21 | Food and Beverage | Cash or cash equivalent | OPDIVO Biological, Oncology | 2024 | |
| 2024-08-05 | PFIZER INC. | $15 | Food and Beverage | In-kind items and services | ELREXFIO Drug, ONCOLOGY | 2024 |
The latest 200 records of 872.
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Spring Hill, FL, county Hernando County, FL, state Florida; placed by its city name.
| Measure | Place (city or town) Spring Hill, FL | County Hernando County, FL | State Florida |
|---|---|---|---|
| Population B01003 | 119,983 | 207,018 | 22,416,077 |
| Population, 2020 census P1 | 113,568 | 194,515 | 21,538,187 |
| Median age B01002 | 44.0 | 47.7 | 42.6 |
| Under 18 B01001 | 19.8% | 18.5% | 19.5% |
| 65 and over B01001 | 22.8% | 26.4% | 21.3% |
| Households B11001 | 45,571 | 82,475 | 8,752,810 |
| Foreign born B05002 | 9.4% | 8.4% | 21.9% |
| Median household income B19013 | $68,432 | $66,058 | $74,568 |
| Median family income B19113 | $78,635 | $78,643 | $89,891 |
| Per capita income B19301 | $33,037 | $34,458 | $42,609 |
| Poverty rate B17001 | 11.8% | 11.7% | 12.6% |
| Unemployment rate B23025 | 5.5% | 5.3% | 4.8% |
| Civilian labor force B23025 | 53,759 | 89,617 | 11,016,578 |
| Mean commute (minutes) B08013 | 29.8 | 31.4 | 28.0 |
| Bachelor's degree or higher B15003 | 19.9% | 21.1% | 34.1% |
| Housing units B25001 | 48,996 | 92,535 | 10,256,470 |
| Owner-occupied B25003 | 80.3% | 82.5% | 67.6% |
| Renters B25003 | 19.7% | 17.5% | 32.4% |
| Median home value B25077 | $288,500 | $276,000 | $359,000 |
| Median gross rent B25064 | $1,440 | $1,298 | $1,669 |
| White, not Hispanic B03002 | 67.2% | 72.1% | 50.4% |
| Black B03002 | 5.0% | 4.7% | 14.6% |
| Hispanic or Latino B03002 | 20.5% | 17.0% | 27.4% |
| Asian B03002 | 1.8% | 1.3% | 2.9% |
| American Indian and Alaska Native B03002 | 0.2% | 0.2% | 0.1% |
Economy now FRED unemployment 4.4% in Sep 2026 (4.2% a year earlier); per capita personal income $78,345 in 2025, up 38% in five years (+11.3% after inflation); the state; Source: FRED, Federal Reserve Bank of St. Louis.
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Spring Hill, FL.
Comments